Screener
ADMA Biologics ADMA Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 528,203 | 466,512 |
| Property and equipment, net | 66,664 | 65,057 |
| Intangible assets, net | 575 | 632 |
| Goodwill | 3,530 | 3,530 |
| Deferred tax assets, net | 69,965 | 73,261 |
| Right-of-use assets | 6,146 | 6,650 |
| Deposits and other assets | 9,127 | 8,600 |
| TOTAL ASSETS | $$684,210 | 624,242 |
Item 1. Financial Statements.
FAQ
- What is ADMA Biologics's goodwill?
- ADMA Biologics (ADMA) reported goodwill of $3.53M in Q2 2026.
- How has ADMA Biologics's goodwill changed year-over-year?
- ADMA Biologics's goodwill decreased by 0.0% year-over-year, from $3.53M to $3.53M.
- What is the long-term trend for ADMA Biologics's goodwill?
- Over 5 years (2020 to 2025), ADMA Biologics's goodwill has grown at a 0.0% compound annual growth rate (CAGR), from $3.53M to $3.53M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.
Ask your AI about ADMA Biologics's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude